0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-32W3031
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Editing Market Size Status and Forecast 2022 2028
BUY CHAPTERS

Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32W3031
Report
September 2024
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Editing - Market Size

The global market for Gene Editing was estimated to be worth US$ 3093.1 million in 2023 and is forecast to a readjusted size of US$ 5441.3 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030

Gene Editing - Market

Gene Editing - Market

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Editing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Editing by region & country, by Type, and by Application.
The Gene Editing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing.
Market Segmentation

Scope of Gene Editing - Market Report

Report Metric Details
Report Name Gene Editing - Market
Forecasted market size in 2030 US$ 5441.3 million
CAGR 7.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Zinc finger nucleases (ZFNs)
  • Transcription Activator-Like Effector-based Nucleases (TALENs)
  • CRISPR-Cas system
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Merck, Horizo​​n Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics, RGen Solutions, Sigma-Aldrich, GeneCopoeia, Genscript Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Gene Editing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Gene Editing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Gene Editing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Gene Editing - Market size in 2030?

Ans: The Gene Editing - Market size in 2030 will be US$ 5441.3 million.

Who are the main players in the Gene Editing - Market report?

Ans: The main players in the Gene Editing - Market are Thermo Fisher Scientific, Merck, Horizo​​n Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics, RGen Solutions, Sigma-Aldrich, GeneCopoeia, Genscript Biotech

What are the Application segmentation covered in the Gene Editing - Market report?

Ans: The Applications covered in the Gene Editing - Market report are Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations

What are the Type segmentation covered in the Gene Editing - Market report?

Ans: The Types covered in the Gene Editing - Market report are Zinc finger nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas system

Recommended Reports

Gene Editing Platforms

Gene Therapy Market

Genome Tools & Reagents

1 Market Overview
1.1 Gene Editing Product Introduction
1.2 Global Gene Editing Market Size Forecast
1.3 Gene Editing Market Trends & Drivers
1.3.1 Gene Editing Industry Trends
1.3.2 Gene Editing Market Drivers & Opportunity
1.3.3 Gene Editing Market Challenges
1.3.4 Gene Editing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Editing Players Revenue Ranking (2023)
2.2 Global Gene Editing Revenue by Company (2019-2024)
2.3 Key Companies Gene Editing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Editing Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Editing
2.6 Gene Editing Market Competitive Analysis
2.6.1 Gene Editing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Editing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Zinc finger nucleases (ZFNs)
3.1.2 Transcription Activator-Like Effector-based Nucleases (TALENs)
3.1.3 CRISPR-Cas system
3.2 Global Gene Editing Sales Value by Type
3.2.1 Global Gene Editing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Editing Sales Value, by Type (2019-2030)
3.2.3 Global Gene Editing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology & Pharmaceutical Companies
4.1.2 Academic & Government Research Institutes
4.1.3 Contract Research Organizations
4.2 Global Gene Editing Sales Value by Application
4.2.1 Global Gene Editing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Editing Sales Value, by Application (2019-2030)
4.2.3 Global Gene Editing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Editing Sales Value by Region
5.1.1 Global Gene Editing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Editing Sales Value by Region (2019-2024)
5.1.3 Global Gene Editing Sales Value by Region (2025-2030)
5.1.4 Global Gene Editing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Editing Sales Value, 2019-2030
5.2.2 North America Gene Editing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Editing Sales Value, 2019-2030
5.3.2 Europe Gene Editing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Editing Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Editing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Editing Sales Value, 2019-2030
5.5.2 South America Gene Editing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Editing Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Editing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Editing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Editing Sales Value
6.3 United States
6.3.1 United States Gene Editing Sales Value, 2019-2030
6.3.2 United States Gene Editing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Editing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Editing Sales Value, 2019-2030
6.4.2 Europe Gene Editing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Editing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Editing Sales Value, 2019-2030
6.5.2 China Gene Editing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Editing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Editing Sales Value, 2019-2030
6.6.2 Japan Gene Editing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Editing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Editing Sales Value, 2019-2030
6.7.2 South Korea Gene Editing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Editing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Editing Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Editing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Editing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Editing Sales Value, 2019-2030
6.9.2 India Gene Editing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Editing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Gene Editing Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Gene Editing Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Gene Editing Products, Services and Solutions
7.2.4 Merck Gene Editing Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Horizo​​n Discovery
7.3.1 Horizo​​n Discovery Profile
7.3.2 Horizo​​n Discovery Main Business
7.3.3 Horizo​​n Discovery Gene Editing Products, Services and Solutions
7.3.4 Horizo​​n Discovery Gene Editing Revenue (US$ Million) & (2019-2024)
7.3.5 Sangamo BioSciences Recent Developments
7.4 Sangamo BioSciences
7.4.1 Sangamo BioSciences Profile
7.4.2 Sangamo BioSciences Main Business
7.4.3 Sangamo BioSciences Gene Editing Products, Services and Solutions
7.4.4 Sangamo BioSciences Gene Editing Revenue (US$ Million) & (2019-2024)
7.4.5 Sangamo BioSciences Recent Developments
7.5 Integrated DNA Technologies
7.5.1 Integrated DNA Technologies Profile
7.5.2 Integrated DNA Technologies Main Business
7.5.3 Integrated DNA Technologies Gene Editing Products, Services and Solutions
7.5.4 Integrated DNA Technologies Gene Editing Revenue (US$ Million) & (2019-2024)
7.5.5 Integrated DNA Technologies Recent Developments
7.6 Lonza
7.6.1 Lonza Profile
7.6.2 Lonza Main Business
7.6.3 Lonza Gene Editing Products, Services and Solutions
7.6.4 Lonza Gene Editing Revenue (US$ Million) & (2019-2024)
7.6.5 Lonza Recent Developments
7.7 New England Biolabs
7.7.1 New England Biolabs Profile
7.7.2 New England Biolabs Main Business
7.7.3 New England Biolabs Gene Editing Products, Services and Solutions
7.7.4 New England Biolabs Gene Editing Revenue (US$ Million) & (2019-2024)
7.7.5 New England Biolabs Recent Developments
7.8 OriGene Technologies
7.8.1 OriGene Technologies Profile
7.8.2 OriGene Technologies Main Business
7.8.3 OriGene Technologies Gene Editing Products, Services and Solutions
7.8.4 OriGene Technologies Gene Editing Revenue (US$ Million) & (2019-2024)
7.8.5 OriGene Technologies Recent Developments
7.9 Transposagen Biopharmaceuticals
7.9.1 Transposagen Biopharmaceuticals Profile
7.9.2 Transposagen Biopharmaceuticals Main Business
7.9.3 Transposagen Biopharmaceuticals Gene Editing Products, Services and Solutions
7.9.4 Transposagen Biopharmaceuticals Gene Editing Revenue (US$ Million) & (2019-2024)
7.9.5 Transposagen Biopharmaceuticals Recent Developments
7.10 Editas Medicine
7.10.1 Editas Medicine Profile
7.10.2 Editas Medicine Main Business
7.10.3 Editas Medicine Gene Editing Products, Services and Solutions
7.10.4 Editas Medicine Gene Editing Revenue (US$ Million) & (2019-2024)
7.10.5 Editas Medicine Recent Developments
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Profile
7.11.2 CRISPR Therapeutics Main Business
7.11.3 CRISPR Therapeutics Gene Editing Products, Services and Solutions
7.11.4 CRISPR Therapeutics Gene Editing Revenue (US$ Million) & (2019-2024)
7.11.5 CRISPR Therapeutics Recent Developments
7.12 RGen Solutions
7.12.1 RGen Solutions Profile
7.12.2 RGen Solutions Main Business
7.12.3 RGen Solutions Gene Editing Products, Services and Solutions
7.12.4 RGen Solutions Gene Editing Revenue (US$ Million) & (2019-2024)
7.12.5 RGen Solutions Recent Developments
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Profile
7.13.2 Sigma-Aldrich Main Business
7.13.3 Sigma-Aldrich Gene Editing Products, Services and Solutions
7.13.4 Sigma-Aldrich Gene Editing Revenue (US$ Million) & (2019-2024)
7.13.5 Sigma-Aldrich Recent Developments
7.14 GeneCopoeia
7.14.1 GeneCopoeia Profile
7.14.2 GeneCopoeia Main Business
7.14.3 GeneCopoeia Gene Editing Products, Services and Solutions
7.14.4 GeneCopoeia Gene Editing Revenue (US$ Million) & (2019-2024)
7.14.5 GeneCopoeia Recent Developments
7.15 Genscript Biotech
7.15.1 Genscript Biotech Profile
7.15.2 Genscript Biotech Main Business
7.15.3 Genscript Biotech Gene Editing Products, Services and Solutions
7.15.4 Genscript Biotech Gene Editing Revenue (US$ Million) & (2019-2024)
7.15.5 Genscript Biotech Recent Developments
8 Industry Chain Analysis
8.1 Gene Editing Industrial Chain
8.2 Gene Editing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Editing Sales Model
8.5.2 Sales Channel
8.5.3 Gene Editing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Gene Editing Market Trends
    Table 2. Gene Editing Market Drivers & Opportunity
    Table 3. Gene Editing Market Challenges
    Table 4. Gene Editing Market Restraints
    Table 5. Global Gene Editing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Gene Editing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Gene Editing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Gene Editing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Gene Editing
    Table 10. Global Gene Editing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Gene Editing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Gene Editing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Gene Editing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Gene Editing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Gene Editing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Gene Editing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Gene Editing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Gene Editing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Gene Editing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Gene Editing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Gene Editing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Gene Editing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Gene Editing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Gene Editing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Gene Editing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Gene Editing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Gene Editing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Gene Editing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermo Fisher Scientific Basic Information List
    Table 32. Thermo Fisher Scientific Description and Business Overview
    Table 33. Thermo Fisher Scientific Gene Editing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Gene Editing Business of Thermo Fisher Scientific (2019-2024)
    Table 35. Thermo Fisher Scientific Recent Developments
    Table 36. Merck Basic Information List
    Table 37. Merck Description and Business Overview
    Table 38. Merck Gene Editing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Gene Editing Business of Merck (2019-2024)
    Table 40. Merck Recent Developments
    Table 41. Horizo​​n Discovery Basic Information List
    Table 42. Horizo​​n Discovery Description and Business Overview
    Table 43. Horizo​​n Discovery Gene Editing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Gene Editing Business of Horizo​​n Discovery (2019-2024)
    Table 45. Horizo​​n Discovery Recent Developments
    Table 46. Sangamo BioSciences Basic Information List
    Table 47. Sangamo BioSciences Description and Business Overview
    Table 48. Sangamo BioSciences Gene Editing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Gene Editing Business of Sangamo BioSciences (2019-2024)
    Table 50. Sangamo BioSciences Recent Developments
    Table 51. Integrated DNA Technologies Basic Information List
    Table 52. Integrated DNA Technologies Description and Business Overview
    Table 53. Integrated DNA Technologies Gene Editing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Gene Editing Business of Integrated DNA Technologies (2019-2024)
    Table 55. Integrated DNA Technologies Recent Developments
    Table 56. Lonza Basic Information List
    Table 57. Lonza Description and Business Overview
    Table 58. Lonza Gene Editing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Gene Editing Business of Lonza (2019-2024)
    Table 60. Lonza Recent Developments
    Table 61. New England Biolabs Basic Information List
    Table 62. New England Biolabs Description and Business Overview
    Table 63. New England Biolabs Gene Editing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Gene Editing Business of New England Biolabs (2019-2024)
    Table 65. New England Biolabs Recent Developments
    Table 66. OriGene Technologies Basic Information List
    Table 67. OriGene Technologies Description and Business Overview
    Table 68. OriGene Technologies Gene Editing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Gene Editing Business of OriGene Technologies (2019-2024)
    Table 70. OriGene Technologies Recent Developments
    Table 71. Transposagen Biopharmaceuticals Basic Information List
    Table 72. Transposagen Biopharmaceuticals Description and Business Overview
    Table 73. Transposagen Biopharmaceuticals Gene Editing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Gene Editing Business of Transposagen Biopharmaceuticals (2019-2024)
    Table 75. Transposagen Biopharmaceuticals Recent Developments
    Table 76. Editas Medicine Basic Information List
    Table 77. Editas Medicine Description and Business Overview
    Table 78. Editas Medicine Gene Editing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Gene Editing Business of Editas Medicine (2019-2024)
    Table 80. Editas Medicine Recent Developments
    Table 81. CRISPR Therapeutics Basic Information List
    Table 82. CRISPR Therapeutics Description and Business Overview
    Table 83. CRISPR Therapeutics Gene Editing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Gene Editing Business of CRISPR Therapeutics (2019-2024)
    Table 85. CRISPR Therapeutics Recent Developments
    Table 86. RGen Solutions Basic Information List
    Table 87. RGen Solutions Description and Business Overview
    Table 88. RGen Solutions Gene Editing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Gene Editing Business of RGen Solutions (2019-2024)
    Table 90. RGen Solutions Recent Developments
    Table 91. Sigma-Aldrich Basic Information List
    Table 92. Sigma-Aldrich Description and Business Overview
    Table 93. Sigma-Aldrich Gene Editing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Gene Editing Business of Sigma-Aldrich (2019-2024)
    Table 95. Sigma-Aldrich Recent Developments
    Table 96. GeneCopoeia Basic Information List
    Table 97. GeneCopoeia Description and Business Overview
    Table 98. GeneCopoeia Gene Editing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Gene Editing Business of GeneCopoeia (2019-2024)
    Table 100. GeneCopoeia Recent Developments
    Table 101. Genscript Biotech Basic Information List
    Table 102. Genscript Biotech Description and Business Overview
    Table 103. Genscript Biotech Gene Editing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Gene Editing Business of Genscript Biotech (2019-2024)
    Table 105. Genscript Biotech Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Gene Editing Downstream Customers
    Table 109. Gene Editing Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Gene Editing Product Picture
    Figure 2. Global Gene Editing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Gene Editing Report Years Considered
    Figure 5. Global Gene Editing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Editing Revenue in 2023
    Figure 7. Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Zinc finger nucleases (ZFNs) Picture
    Figure 9. Transcription Activator-Like Effector-based Nucleases (TALENs) Picture
    Figure 10. CRISPR-Cas system Picture
    Figure 11. Global Gene Editing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Gene Editing Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Biotechnology & Pharmaceutical Companies
    Figure 14. Product Picture of Academic & Government Research Institutes
    Figure 15. Product Picture of Contract Research Organizations
    Figure 16. Global Gene Editing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Gene Editing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Gene Editing Sales Value (%), (2019-2030)
    Figure 29. United States Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 50. Gene Editing Industrial Chain
    Figure 51. Gene Editing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String